Literature DB >> 19204710

Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation.

S Merante, A A Colombo, S Calatroni, B Rocca, M Boni, P Bernasconi, L Bonvini, S Soverini, E P Alessandrino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19204710     DOI： 10.1038/bmt.2009.6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

Review 1.  Treatment of Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia.

Authors:  Aaron Ronson; Ariella Tvito; Jacob M Rowe
Journal:  Curr Treat Options Oncol       Date:  2017-03

2.  Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.

Authors:  Daniel N Egan; Lan Beppu; Jerald P Radich
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-06       Impact factor: 5.742

Review 3.  Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.

Authors:  Jacopo Olivieri; Sabrina Coluzzi; Imma Attolico; Attilio Olivieri
Journal:  ScientificWorldJournal       Date:  2011-10-25

4.  Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation.

Authors:  Mark Reinwald; Eberhard Schleyer; Philipp Kiewe; Igor Wolfgang Blau; Thomas Burmeister; Stefan Pursche; Martin Neumann; Michael Notter; Eckhard Thiel; Wolf-Karsten Hofmann; Hans-Jochem Kolb; Stefan Burdach; Hans-Ulrich Bender
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

5.  Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation.

Authors:  Paul Farnsworth; David Ward; Vijay Reddy
Journal:  Exp Hematol Oncol       Date:  2012-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.